SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-076891
Filing Date
2015-11-09
Accepted
2015-11-09 06:48:06
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-17950_110q.htm 10-Q 561223
2 EX-31.1 a15-17950_1ex31d1.htm EX-31.1 10555
3 EX-31.2 a15-17950_1ex31d2.htm EX-31.2 10600
4 EX-32.1 a15-17950_1ex32d1.htm EX-32.1 4323
5 EX-32.2 a15-17950_1ex32d2.htm EX-32.2 4883
  Complete submission text file 0001104659-15-076891.txt   3537075

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgyp-20150930.xml EX-101.INS 717402
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20150930.xsd EX-101.SCH 35082
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20150930_cal.xml EX-101.CAL 28690
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20150930_def.xml EX-101.DEF 127103
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sgyp-20150930_lab.xml EX-101.LAB 333434
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20150930_pre.xml EX-101.PRE 241153
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35268 | Film No.: 151213923
SIC: 2834 Pharmaceutical Preparations